K093319 is an FDA 510(k) clearance for the NUVASIVE VUEPOINT OCT SYSTEM. Classified as Appliance, Fixation, Spinal Interlaminal (product code KWP), Class II - Special Controls.
Submitted by Nuvasive, Inc. (San Diego, US). The FDA issued a Cleared decision on June 23, 2010 after a review of 243 days - an extended review cycle.
This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3050 - the FDA orthopedic device regulatory framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.
Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.